(Q43715663)

26 November 2017

title

Lofexidine versus clonidine in rapid opiate detoxification (English)

1 reference

26 November 2017

Gerra G

1

1 reference

26 November 2017

Zaimovic A

2

1 reference

26 November 2017

Giusti F

3

1 reference

26 November 2017

Di Gennaro C

4

1 reference

26 November 2017

Zambelli U

5

1 reference

26 November 2017

Gardini S

6

1 reference

26 November 2017

Delsignore R

7

1 reference

26 November 2017

publication date

1 July 2001

1 reference

Journal of Substance Abuse Treatment

26 November 2017

published in

1 reference

26 November 2017

volume

21

1 reference

26 November 2017

issue

1

1 reference

26 November 2017

page(s)

11-17

1 reference

The use of lofexidine by drug dependency units in the United Kingdom

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

Perikaryal and synaptic localization of alpha 2A-adrenergic receptor-like immunoreactivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

Rapid opiate detoxification.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

Efficacy of clonidine and of methadone in the rapid detoxification of patients dependent on heroin

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

Randomised double-blind comparison of lofexidine and clonidine in the out-patient treatment of opiate withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

Adrenergic receptor sensitivity in depression. Effects of clonidine in depressed patients and healthy subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

Craving and drug reward: a comparison of methadone and clonidine in detoxifying opiate addicts.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

[Opiate withdrawal in anesthesia (forced narcotic withdrawal, "turbo withdrawal") in narcotic dependence. Changes in withdrawal treatment--wishes and reality]

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

Alpha-2-adrenoceptor sensitivity in heroin addicts with and without previous attention deficit disorder/hyperactivity and conduct disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

Noradrenergic and hormonal responses to physical exercise in adolescents. Relationship to anxiety and tolerance to frustration.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

The Atwood Hall Health Promotion Program, Federal Medical Center, Lexington, KY. Effects on drug-involved federal offenders

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

Rapid opiate detoxication in outpatient treatment: relationship with naltrexone compliance.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

Efficacy of clonidine in opiate withdrawal: a study of thirty patients

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

Double-blind study of lofexidine and clonidine in the detoxification of opiate addicts in hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

Clonidine in outpatient detoxification from methadone maintenance

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

Clonidine and naltrexone in the outpatient treatment of heroin withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

Comparison of clinician ratings to self reports of withdrawal during clonidine detoxification of opiate addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

The severity of naloxone-precipitated opiate withdrawal is attenuated by felbamate, a possible glycine antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

A 24-h inpatient detoxification treatment for heroin addicts: a preliminary investigation.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

Double-blind randomised controlled trial of lofexidine versus clonidine in the treatment of heroin withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

Primary care-based ambulatory opioid detoxification: the results of a clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

Three methods of opioid detoxification in a primary care setting. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

Opiate detoxification under anesthesia: no apparent benefit but suppression of thyroid hormones and risk of pulmonary and renal failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

Compliance to naltrexone treatment after ultra-rapid opiate detoxification: an open label naturalistic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

Lofexidine for opiate detoxification: review of recent randomised and open controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

Clonidine in opiate withdrawal: review and appraisal of clinical findings

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900178-7

7 January 2021

10.1016/S0740-5472(01)00178-7

Identifiers

DOI

1 reference

26 November 2017

1 reference